Dual Antiplatelet Therapy in Coronary Artery Disease
Abstract Acute coronary syndrome (ACS) is principally driven by platelet aggregation. Dual antiplatelet therapy (DAPT) has demonstrated a reduction in recurrent ischemic events. The newer antiplatelets ticagrelor and prasugrel have demonstrated superiority over clopidogrel. While prasugrel demonstra...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Adis, Springer Healthcare
2020-08-01
|
| coleção: | Cardiology and Therapy |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1007/s40119-020-00197-0 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|